My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 251

    1.

    Chemoprevention of breast cancer: recommendations and rationale.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2002 Jul 2;137(1):56-8. No abstract available. PMID: 12093249 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Using medication to prevent breast cancer: recommendations from the United States Preventive Services Task Force.

    [No authors listed]

    Ann Intern Med. 2002 Jul 2;137(1):I62. No abstract available. PMID: 12093267 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.

    [No authors listed]

    Harv Womens Health Watch. 2002 Oct;10(2):1-2. No abstract available. PMID: 12393316 [PubMed - indexed for MEDLINE]Related articles

    4.

    Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.

    Kinsinger LS, Harris R, Woolf SH, Sox HC, Lohr KN.

    Ann Intern Med. 2002 Jul 2;137(1):59-69. Review.PMID: 12093250 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Chemoprevention of breast cancer: recommendations and rationale.

    Berg AO; U.S. Preventive Services Task Force.

    Am J Nurs. 2003 May;103(5):107, 109, 111, 113. No abstract available. PMID: 12759615 [PubMed - indexed for MEDLINE]Related articles

    6.

    Raloxifene works as well as tamoxifen in preventing invasive breast cancer.

    [No authors listed]

    Mayo Clin Womens Healthsource. 2006 Oct;10(10):3. No abstract available. PMID: 16977270 [PubMed - indexed for MEDLINE]Related articles

    7.

    Chemoprevention of breast cancer: recommendations and rationale.

    [No authors listed]

    Am Fam Physician. 2003 Mar 15;67(6):1309-14. Review. No abstract available. PMID: 12674459 [PubMed - indexed for MEDLINE]Related articles

    8.

    Chemoprevention of breast cancer.

    Thomsen A, Kolesar JM.

    Am J Health Syst Pharm. 2008 Dec 1;65(23):2221-8. Review.PMID: 19020189 [PubMed - indexed for MEDLINE]Related articles

    9.

    Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.

    Jordan VC.

    Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2207-9. No abstract available. PMID: 18006908 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Chemoprevention of breast cancer.

    Zelnak AB, O'Regan RM.

    Curr Probl Cancer. 2004 Jul-Aug;28(4):201-17. Review. No abstract available. PMID: 15318323 [PubMed - indexed for MEDLINE]Related articles

    11.

    The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.

    Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Wolmark N.

    Clin Breast Cancer. 2002 Jun;3(2):153-9.PMID: 12123540 [PubMed - indexed for MEDLINE]Related articles

    12.

    Primary prevention of breast cancer: new approaches.

    Cummings SR.

    Maturitas. 2007 May 20;57(1):39-41. Epub 2007 Mar 27. Review.PMID: 17391879 [PubMed - indexed for MEDLINE]Related articles

    13.

    Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

    Levine M, Moutquin JM, Walton R, Feightner J; Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

    CMAJ. 2001 Jun 12;164(12):1681-90. Review.PMID: 11450210 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Tamoxifen and raloxifene may benefit women at high risk for breast cancer.

    Rollins G.

    Rep Med Guidel Outcomes Res. 2002 Jul 26;13(14):1-2, 5. No abstract available. PMID: 12518771 [PubMed - indexed for MEDLINE]Related articles

    15.

    Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.

    Fabian C.

    Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2210-2. No abstract available. PMID: 18006909 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention]

    Ricart JJ.

    Medicina (B Aires). 2004;64(1):66-72. Spanish. PMID: 15034961 [PubMed - indexed for MEDLINE]Related articles

    17.

    Chemoprevention of breast cancer.

    Dalton RR, Kallab AM.

    South Med J. 2001 Jan;94(1):7-15. Review.PMID: 11213947 [PubMed - indexed for MEDLINE]Related articles

    18.

    Budget impact analysis of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.

    Kondo M, Hoshi SL, Toi M.

    Jpn J Clin Oncol. 2009 Nov;39(11):767-70. Epub 2009 Aug 5.PMID: 19656807 [PubMed - indexed for MEDLINE]Related articles

    19.

    Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

    Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH.

    J Natl Cancer Inst. 2003 Apr 2;95(7):526-32.PMID: 12671020 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Breast cancer chemoprevention: current clinical practice and future direction.

    Bevers TB.

    Biomed Pharmacother. 2001 Nov;55(9-10):559-64. Review.PMID: 11769967 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity